NorthWest Biotherapeutics Inc (NWBO)

[DoGood_DoWell]

Left to its own devices and efficacy of their products, NWBO would be able to progress relatively quickly toward approval for two products that could be used to treat a large variety of different types of cancers with virtually no side effects and become the new paradigm for treating solid tumor cancers. Given the manufacturing technology being developed, costs appear they will be reasonable compared to some of the other technologies and combination therapies being developed. So a strategy to slow down, interfere with normal course of business, interfere with the company's ability to garner resources, interfere with the stock price, etc. etc. etc. has become a new normal in biotech according to some articles. Delay one company so that others can get approved first. We get it. It is beyond obvious to most of this at this point. The question is, what are we going to do about it? I would recommend complaining to any and every relevant authority with as much data as you can put together. The authorities need to know how this kind of organized coordinated effort is harming patients, investors, the economy, and progress on fighting cancer. If the Obama administration wants to leave a legacy of making a difference on cancer, they would be smart and effective in their efforts by backing NWBO - or at least stopping those who are sabotaging and standing in the way.